Gina Vitale

Washington, D.C., United States

Associate Editor at C&EN

Editor of freelance news/features @cenmag and creative writer @ my living room couch. Words in @phillyinquirer, @novapbs, @penn_today + more.

Featured in: Favicon

acs.org

medium.com Favicon

pbs.org

medicalxpress.com Favicon

techxplore.com Favicon

thepigsite.com Favicon

thetriangle.org Favicon

healthnews.com Favicon

inquirer.com Favicon

cen.acs.org

Articles

The many materials that made microplastics possible

1 month ago | cen.acs.org | David Anderson |Gina Vitale

C &EN's latest podcast, Inflection Point, leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.
The mind-bending innovations that built quantum computing

1 month ago | cen.acs.org | David Anderson |Gina Vitale

C&EN's latest podcast, Inflection Point, leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.
The serendipitous origins of 'forever chemicals'

2 months ago | cen.acs.org | David Anderson |Gina Vitale

C&EN's latest podcast Inflection Point leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.
An Open Letter to the Credit Card Company Who Thinks I Stole My Identity

2 months ago | thebelladonnacomedy.com | Gina Vitale

If I were stealing a life, I probably wouldn’t choose someone whose daily highlight is the NYT Connections puzzle. Dear Credit Card Application Reviewer,Thank you for your letter, which I still think you could have emailed, warning me that someone may have stolen my identity to apply for your pretty blue credit card. While I appreciate your vigilance — criminal masses, take note! — I promise I filled out that application myself, and am willing to sign an affidavit to that effect.
'Inflection Point' podcast explores history of green hydrogen

2 months ago | cen.acs.org | David Anderson |Gina Vitale

The new podcast Inflection Point leans on C&EN's 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.
Macy's is closing, but I hope the eagle can still be a meeting place

Jan 13, 2025 | inquirer.com | Gina Vitale

I don’t remember the first time I saw the Christmas light show in the Center City Macy’s. I remember the fourth or fifth time, when I was old enough to sit quietly on the floor, because the worst ear infection I ever had arose right in the middle of it. I squeezed my head with my hands on either side, focusing on the lights’ colorful glow, while my father ran out past the giant bronze eagle and over to the nearest CVS.
Kynexis sets sights on schizophrenia with $61 million

Nov 10, 2023 | cen.acs.org | Gina Vitale

People with schizophrenia may experience a variety of symptoms, including hallucinations, delusions, or being unable to feel pleasure. They may also have cognitive symptoms; for instance, they may struggle to pay attention or have problems with memory. Kynexis, a new Dutch start-up, is developing a drug that they hope will be able to treat cognitive impairment associated with schizophrenia (CIAS), a condition for which no drugs have been approved. "It's a large population.
Gate Bioscience launches to stop bad proteins at their source

Nov 1, 2023 | cen.acs.org | Gina Vitale

Drug designers try many different tricks to degrade badly behaving proteins. Much of the action in that space comes from companies developing small molecules like proteolysis targeting chimeras (PROTACs), which degrade proteins that operate inside the cell. Gate Bioscience, a Versant Ventures-backed start-up that launched today with $60 million in series A funding, has set its sights on disease-causing proteins that are destined for outside the cell.
The race to report on the Nobel Prizes

Oct 31, 2023 | cen.acs.org | Gina Vitale |Brian Gutiérrez

The Nobel Prize announcements are big events at Chemical & Engineering News. But we find out the winners at the same time as everyone else. Then, the race is on for our reporters. This year, staffers Laurel Oldach and Mitch Jacoby took on the task of covering the science prizes. In this episode, they reflect on this year's winning research in chemistry and medicine and share what it's like covering some of the most prestigious prizes in science.
Molecular glue deals abound

Oct 5, 2023 | cen.acs.org | Gina Vitale

Two recent deals in molecular glues come hot on the heels of the launch of Magnet Biomedicine, a glues-focused start-up. On Sept. 20, Orionis Biosciences said that it would be teaming up with Genentech-owned by Roche-to discover and develop glues; on Sept 26, A-Alpha Bio and Amgen announced that they would be expanding a glue partnership struck last year. Molecular glues are monovalent small molecules that draw two proteins into close proximity with each other.